APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumonia Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pneumonia Vaccine Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchPneumonia Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumonia Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pneumonia Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumonia Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumonia Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pneumonia Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pneumonia Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pneumonia Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pneumonia Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pneumonia Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pneumonia Vaccine include Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Glaxosmithkline Plc., Zhifei Biologic, Walvax Biotechnology, Serum Institute of India Pvt. Ltd., Sanofi Pasteur and Royal (Wuxi) Bio-Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pneumonia Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pneumonia Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumonia Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pneumonia Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pneumonia Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pneumonia Vaccine sales, projected growth trends, production technology, application and end-user industry.

Pneumonia Vaccine Segment by Company

Johnson & Johnson

Merck & Co., Inc.

Pfizer Inc.

Glaxosmithkline Plc.

Zhifei Biologic

Walvax Biotechnology

Serum Institute of India Pvt. Ltd.

Sanofi Pasteur

Royal (Wuxi) Bio-Pharmaceutical

Emergent Biosolutions

CSL Limited

Astrazeneca Plc.

Astellas Pharma Inc.

Pneumonia Vaccine Segment by Type

Pneumococcal Conjugate Vaccine (PCV13)

Pneumococcal Polysaccharide Vaccine (PPSV23)

Other

Pneumonia Vaccine Segment by Application

Sepsis

Meningitis

Pneumonia

Pneumonia Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumonia Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumonia Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumonia Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pneumonia Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pneumonia Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumonia Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pneumonia Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pneumococcal Conjugate Vaccine (PCV13) Major Manufacturers Table 3. Pneumococcal Polysaccharide Vaccine (PPSV23) Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Pneumonia Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Sepsis Major Manufacturers Table 7. Meningitis Major Manufacturers Table 8. Pneumonia Major Manufacturers Table 9. Pneumonia Vaccine Industry Trends Table 10. Pneumonia Vaccine Industry Drivers Table 11. Pneumonia Vaccine Industry Opportunities and Challenges Table 12. Pneumonia Vaccine Industry Restraints Table 13. Global Pneumonia Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pneumonia Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pneumonia Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pneumonia Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Pneumonia Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Pneumonia Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (doses) Table 19. Global Pneumonia Vaccine Sales by Region (2021-2026) & (doses) Table 20. Global Pneumonia Vaccine Sales by Region (2027-2032) & (doses) Table 21. Global Pneumonia Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Pneumonia Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Pneumonia Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pneumonia Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pneumonia Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pneumonia Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pneumonia Vaccine Sales Price (US$/dose) of Manufacturers (2021-2026) Table 28. Global Pneumonia Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pneumonia Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pneumonia Vaccine Manufacturers, Product Type & Application Table 31. Global Pneumonia Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pneumonia Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pneumonia Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pneumonia Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pneumonia Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pneumonia Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Pneumonia Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Pneumonia Vaccine Sales by Type 2021 VS 2025 VS 2032 (doses) Table 40. Global Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 41. Global Pneumonia Vaccine Sales by Type (2027-2032) & (doses) Table 42. Global Pneumonia Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Pneumonia Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Pneumonia Vaccine Price by Type (2021-2026) & (US$/dose) Table 45. Global Pneumonia Vaccine Price by Type (2027-2032) & (US$/dose) Table 46. Global Pneumonia Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pneumonia Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pneumonia Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pneumonia Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Pneumonia Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Pneumonia Vaccine Sales by Application 2021 VS 2025 VS 2032 (doses) Table 52. Global Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 53. Global Pneumonia Vaccine Sales by Application (2027-2032) & (doses) Table 54. Global Pneumonia Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Pneumonia Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Pneumonia Vaccine Price by Application (2021-2026) & (US$/dose) Table 57. Global Pneumonia Vaccine Price by Application (2027-2032) & (US$/dose) Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Pneumonia Vaccine Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. Merck & Co., Inc. Company Information Table 64. Merck & Co., Inc. Business Overview Table 65. Merck & Co., Inc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 66. Merck & Co., Inc. Pneumonia Vaccine Product Portfolio Table 67. Merck & Co., Inc. Recent Development Table 68. Pfizer Inc. Company Information Table 69. Pfizer Inc. Business Overview Table 70. Pfizer Inc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 71. Pfizer Inc. Pneumonia Vaccine Product Portfolio Table 72. Pfizer Inc. Recent Development Table 73. Glaxosmithkline Plc. Company Information Table 74. Glaxosmithkline Plc. Business Overview Table 75. Glaxosmithkline Plc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 76. Glaxosmithkline Plc. Pneumonia Vaccine Product Portfolio Table 77. Glaxosmithkline Plc. Recent Development Table 78. Zhifei Biologic Company Information Table 79. Zhifei Biologic Business Overview Table 80. Zhifei Biologic Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 81. Zhifei Biologic Pneumonia Vaccine Product Portfolio Table 82. Zhifei Biologic Recent Development Table 83. Walvax Biotechnology Company Information Table 84. Walvax Biotechnology Business Overview Table 85. Walvax Biotechnology Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 86. Walvax Biotechnology Pneumonia Vaccine Product Portfolio Table 87. Walvax Biotechnology Recent Development Table 88. Serum Institute of India Pvt. Ltd. Company Information Table 89. Serum Institute of India Pvt. Ltd. Business Overview Table 90. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 91. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Portfolio Table 92. Serum Institute of India Pvt. Ltd. Recent Development Table 93. Sanofi Pasteur Company Information Table 94. Sanofi Pasteur Business Overview Table 95. Sanofi Pasteur Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 96. Sanofi Pasteur Pneumonia Vaccine Product Portfolio Table 97. Sanofi Pasteur Recent Development Table 98. Royal (Wuxi) Bio-Pharmaceutical Company Information Table 99. Royal (Wuxi) Bio-Pharmaceutical Business Overview Table 100. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 101. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Portfolio Table 102. Royal (Wuxi) Bio-Pharmaceutical Recent Development Table 103. Emergent Biosolutions Company Information Table 104. Emergent Biosolutions Business Overview Table 105. Emergent Biosolutions Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 106. Emergent Biosolutions Pneumonia Vaccine Product Portfolio Table 107. Emergent Biosolutions Recent Development Table 108. CSL Limited Company Information Table 109. CSL Limited Business Overview Table 110. CSL Limited Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 111. CSL Limited Pneumonia Vaccine Product Portfolio Table 112. CSL Limited Recent Development Table 113. Astrazeneca Plc. Company Information Table 114. Astrazeneca Plc. Business Overview Table 115. Astrazeneca Plc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 116. Astrazeneca Plc. Pneumonia Vaccine Product Portfolio Table 117. Astrazeneca Plc. Recent Development Table 118. Astellas Pharma Inc. Company Information Table 119. Astellas Pharma Inc. Business Overview Table 120. Astellas Pharma Inc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 121. Astellas Pharma Inc. Pneumonia Vaccine Product Portfolio Table 122. Astellas Pharma Inc. Recent Development Table 123. North America Pneumonia Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Pneumonia Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 126. North America Pneumonia Vaccine Sales by Type (2027-2032) & (doses) Table 127. North America Pneumonia Vaccine Sales Price by Type (2021-2026) & (US$/dose) Table 128. North America Pneumonia Vaccine Sales Price by Type (2027-2032) & (US$/dose) Table 129. North America Pneumonia Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Pneumonia Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 132. North America Pneumonia Vaccine Sales by Application (2027-2032) & (doses) Table 133. North America Pneumonia Vaccine Sales Price by Application (2021-2026) & (US$/dose) Table 134. North America Pneumonia Vaccine Sales Price by Application (2027-2032) & (US$/dose) Table 135. North America Pneumonia Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Pneumonia Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Pneumonia Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Pneumonia Vaccine Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 139. North America Pneumonia Vaccine Sales by Country (2021-2026) & (doses) Table 140. North America Pneumonia Vaccine Sales by Country (2027-2032) & (doses) Table 141. North America Pneumonia Vaccine Sales Price by Country (2021-2026) & (US$/dose) Table 142. North America Pneumonia Vaccine Sales Price by Country (2027-2032) & (US$/dose) Table 143. United States Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Canada Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 145. Mexico Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 146. Europe Pneumonia Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Pneumonia Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 149. Europe Pneumonia Vaccine Sales by Type (2027-2032) & (doses) Table 150. Europe Pneumonia Vaccine Sales Price by Type (2021-2026) & (US$/dose) Table 151. Europe Pneumonia Vaccine Sales Price by Type (2027-2032) & (US$/dose) Table 152. Europe Pneumonia Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Pneumonia Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 155. Europe Pneumonia Vaccine Sales by Application (2027-2032) & (doses) Table 156. Europe Pneumonia Vaccine Sales Price by Application (2021-2026) & (US$/dose) Table 157. Europe Pneumonia Vaccine Sales Price by Application (2027-2032) & (US$/dose) Table 158. Europe Pneumonia Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Pneumonia Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Pneumonia Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Pneumonia Vaccine Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 162. Europe Pneumonia Vaccine Sales by Country (2021-2026) & (doses) Table 163. Europe Pneumonia Vaccine Sales by Country (2027-2032) & (doses) Table 164. Europe Pneumonia Vaccine Sales Price by Country (2021-2026) & (US$/dose) Table 165. Europe Pneumonia Vaccine Sales Price by Country (2027-2032) & (US$/dose) Table 166. Germany Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 167. France Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 168. U.K. Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 169. Italy Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 170. Russia Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 171. Spain Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 174. Sweden Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 175. Poland Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 176. China Pneumonia Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 177. China Pneumonia Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 178. China Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 179. China Pneumonia Vaccine Sales by Type (2027-2032) & (doses) Table 180. China Pneumonia Vaccine Sales Price by Type (2021-2026) & (US$/dose) Table 181. China Pneumonia Vaccine Sales Price by Type (2027-2032) & (US$/dose) Table 182. China Pneumonia Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 183. China Pneumonia Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 184. China Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 185. China Pneumonia Vaccine Sales by Application (2027-2032) & (doses) Table 186. China Pneumonia Vaccine Sales Price by Application (2021-2026) & (US$/dose) Table 187. China Pneumonia Vaccine Sales Price by Application (2027-2032) & (US$/dose) Table 188. Asia Pneumonia Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Pneumonia Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 191. Asia Pneumonia Vaccine Sales by Type (2027-2032) & (doses) Table 192. Asia Pneumonia Vaccine Sales Price by Type (2021-2026) & (US$/dose) Table 193. Asia Pneumonia Vaccine Sales Price by Type (2027-2032) & (US$/dose) Table 194. Asia Pneumonia Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Pneumonia Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 197. Asia Pneumonia Vaccine Sales by Application (2027-2032) & (doses) Table 198. Asia Pneumonia Vaccine Sales Price by Application (2021-2026) & (US$/dose) Table 199. Asia Pneumonia Vaccine Sales Price by Application (2027-2032) & (US$/dose) Table 200. Asia Pneumonia Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Pneumonia Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Pneumonia Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Pneumonia Vaccine Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 204. Asia Pneumonia Vaccine Sales by Country (2021-2026) & (doses) Table 205. Asia Pneumonia Vaccine Sales by Country (2027-2032) & (doses) Table 206. Asia Pneumonia Vaccine Sales Price by Country (2021-2026) & (US$/dose) Table 207. Asia Pneumonia Vaccine Sales Price by Country (2027-2032) & (US$/dose) Table 208. Japan Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 209. South Korea Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 210. India Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Australia Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Pneumonia Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Pneumonia Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 217. SAMEA Pneumonia Vaccine Sales by Type (2027-2032) & (doses) Table 218. SAMEA Pneumonia Vaccine Sales Price by Type (2021-2026) & (US$/dose) Table 219. SAMEA Pneumonia Vaccine Sales Price by Type (2027-2032) & (US$/dose) Table 220. SAMEA Pneumonia Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Pneumonia Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 223. SAMEA Pneumonia Vaccine Sales by Application (2027-2032) & (doses) Table 224. SAMEA Pneumonia Vaccine Sales Price by Application (2021-2026) & (US$/dose) Table 225. SAMEA Pneumonia Vaccine Sales Price by Application (2027-2032) & (US$/dose) Table 226. SAMEA Pneumonia Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Pneumonia Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Pneumonia Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Pneumonia Vaccine Sales by Country (2021 VS 2025 VS 2032) & (doses) Table 230. SAMEA Pneumonia Vaccine Sales by Country (2021-2026) & (doses) Table 231. SAMEA Pneumonia Vaccine Sales by Country (2027-2032) & (doses) Table 232. SAMEA Pneumonia Vaccine Sales Price by Country (2021-2026) & (US$/dose) Table 233. SAMEA Pneumonia Vaccine Sales Price by Country (2027-2032) & (US$/dose) Table 234. Brazil Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 235. Argentina Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 236. Chile Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 237. Colombia Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 238. Peru Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 240. Israel Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 241. UAE Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 242. Turkey Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 243. Iran Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 244. Egypt Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Pneumonia Vaccine Distributors List Table 248. Pneumonia Vaccine Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Pneumonia Vaccine Image Figure 2. Global Pneumonia Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumonia Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pneumococcal Conjugate Vaccine (PCV13) Image Figure 5. Pneumococcal Polysaccharide Vaccine (PPSV23) Image Figure 6. Other Image Figure 7. Global Pneumonia Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pneumonia Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Sepsis Image Figure 10. Meningitis Image Figure 11. Pneumonia Image Figure 12. Global Pneumonia Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pneumonia Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Pneumonia Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pneumonia Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pneumonia Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Pneumonia Vaccine Sales (2021-2032) & (doses) Figure 18. Global Pneumonia Vaccine Sales by Region: 2021 VS 2025 VS 2032 (doses) Figure 19. Global Pneumonia Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pneumonia Vaccine Sales YoY (2021-2032) & (doses) Figure 21. Europe Pneumonia Vaccine Sales YoY (2021-2032) & (doses) Figure 22. China Pneumonia Vaccine Sales YoY (2021-2032) & (doses) Figure 23. Asia (Excluding China) Pneumonia Vaccine Sales YoY (2021-2032) & (doses) Figure 24. South America, Middle East and Africa Pneumonia Vaccine Sales YoY (2021-2032) & (doses) Figure 25. Global Pneumonia Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pneumonia Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pneumonia Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pneumonia Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pneumonia Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Pneumonia Vaccine Sales by Type (2021 VS 2025 VS 2032) & (doses) Figure 32. Global Pneumonia Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pneumonia Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Pneumonia Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pneumonia Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pneumonia Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Pneumonia Vaccine Sales by Application (2021 VS 2025 VS 2032) & (doses) Figure 38. Global Pneumonia Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pneumonia Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Pneumonia Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Pneumonia Vaccine Sales Share by Type (2021-2032) Figure 42. North America Pneumonia Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Pneumonia Vaccine Sales Share by Application (2021-2032) Figure 44. North America Pneumonia Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Pneumonia Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Pneumonia Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Pneumonia Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Pneumonia Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Pneumonia Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Pneumonia Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Pneumonia Vaccine Sales Share by Country (2021-2032) Figure 52. China Pneumonia Vaccine Revenue Share by Type (2021-2032) Figure 53. China Pneumonia Vaccine Sales Share by Type (2021-2032) Figure 54. China Pneumonia Vaccine Revenue Share by Application (2021-2032) Figure 55. China Pneumonia Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Pneumonia Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Pneumonia Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Pneumonia Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Pneumonia Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Pneumonia Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Pneumonia Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Pneumonia Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Pneumonia Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Pneumonia Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Pneumonia Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Pneumonia Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Pneumonia Vaccine Sales Share by Country (2021-2032) Figure 68. Pneumonia Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pneumonia Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Pneumococcal Conjugate Vaccine (PCV13)
  • Pneumococcal Polysaccharide Vaccine (PPSV23)
  • Other
Applications
  • Sepsis
  • Meningitis
  • Pneumonia
Companies covered
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Glaxosmithkline Plc.
  • Zhifei Biologic
  • Walvax Biotechnology
  • Serum Institute of India Pvt. Ltd.
  • Sanofi Pasteur
  • Royal (Wuxi) Bio-Pharmaceutical
  • Emergent Biosolutions
  • CSL Limited
  • Astrazeneca Plc.
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pneumonia Vaccine Market by Type
  3. 1.2.1 Global Pneumonia Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
  5. 1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
  6. 1.2.4 Other
  7. 1.3 Pneumonia Vaccine Market by Application
  8. 1.3.1 Global Pneumonia Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Sepsis
  10. 1.3.3 Meningitis
  11. 1.3.4 Pneumonia
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pneumonia Vaccine Market Dynamics
  1. 2.1 Pneumonia Vaccine Industry Trends
  2. 2.2 Pneumonia Vaccine Industry Drivers
  3. 2.3 Pneumonia Vaccine Industry Opportunities and Challenges
  4. 2.4 Pneumonia Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pneumonia Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pneumonia Vaccine Revenue by Region
  3. 3.2.1 Global Pneumonia Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pneumonia Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Pneumonia Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Pneumonia Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pneumonia Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pneumonia Vaccine Sales by Region
  9. 3.4.1 Global Pneumonia Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pneumonia Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Pneumonia Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Pneumonia Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pneumonia Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Pneumonia Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pneumonia Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pneumonia Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pneumonia Vaccine Sales by Manufacturers
  6. 4.2.1 Global Pneumonia Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pneumonia Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pneumonia Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pneumonia Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pneumonia Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pneumonia Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pneumonia Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Pneumonia Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pneumonia Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Pneumonia Vaccine Tier 1, Tier 2, and Tier 3
5 Pneumonia Vaccine Market by Type
  1. 5.1 Global Pneumonia Vaccine Revenue by Type
  2. 5.1.1 Global Pneumonia Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pneumonia Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pneumonia Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pneumonia Vaccine Sales by Type
  6. 5.2.1 Global Pneumonia Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pneumonia Vaccine Sales by Type (2021-2032) & (doses)
  8. 5.2.3 Global Pneumonia Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pneumonia Vaccine Price by Type
6 Pneumonia Vaccine Market by Application
  1. 6.1 Global Pneumonia Vaccine Revenue by Application
  2. 6.1.1 Global Pneumonia Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pneumonia Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pneumonia Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pneumonia Vaccine Sales by Application
  6. 6.2.1 Global Pneumonia Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pneumonia Vaccine Sales by Application (2021-2032) & (doses)
  8. 6.2.3 Global Pneumonia Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pneumonia Vaccine Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Pneumonia Vaccine Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Merck & Co., Inc.
  8. 7.2.1 Merck & Co., Inc. Company Information
  9. 7.2.2 Merck & Co., Inc. Business Overview
  10. 7.2.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co., Inc. Pneumonia Vaccine Product Portfolio
  12. 7.2.5 Merck & Co., Inc. Recent Developments
  13. 7.3 Pfizer Inc.
  14. 7.3.1 Pfizer Inc. Company Information
  15. 7.3.2 Pfizer Inc. Business Overview
  16. 7.3.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Inc. Pneumonia Vaccine Product Portfolio
  18. 7.3.5 Pfizer Inc. Recent Developments
  19. 7.4 Glaxosmithkline Plc.
  20. 7.4.1 Glaxosmithkline Plc. Company Information
  21. 7.4.2 Glaxosmithkline Plc. Business Overview
  22. 7.4.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Glaxosmithkline Plc. Pneumonia Vaccine Product Portfolio
  24. 7.4.5 Glaxosmithkline Plc. Recent Developments
  25. 7.5 Zhifei Biologic
  26. 7.5.1 Zhifei Biologic Company Information
  27. 7.5.2 Zhifei Biologic Business Overview
  28. 7.5.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Zhifei Biologic Pneumonia Vaccine Product Portfolio
  30. 7.5.5 Zhifei Biologic Recent Developments
  31. 7.6 Walvax Biotechnology
  32. 7.6.1 Walvax Biotechnology Company Information
  33. 7.6.2 Walvax Biotechnology Business Overview
  34. 7.6.3 Walvax Biotechnology Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Walvax Biotechnology Pneumonia Vaccine Product Portfolio
  36. 7.6.5 Walvax Biotechnology Recent Developments
  37. 7.7 Serum Institute of India Pvt. Ltd.
  38. 7.7.1 Serum Institute of India Pvt. Ltd. Company Information
  39. 7.7.2 Serum Institute of India Pvt. Ltd. Business Overview
  40. 7.7.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Portfolio
  42. 7.7.5 Serum Institute of India Pvt. Ltd. Recent Developments
  43. 7.8 Sanofi Pasteur
  44. 7.8.1 Sanofi Pasteur Company Information
  45. 7.8.2 Sanofi Pasteur Business Overview
  46. 7.8.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sanofi Pasteur Pneumonia Vaccine Product Portfolio
  48. 7.8.5 Sanofi Pasteur Recent Developments
  49. 7.9 Royal (Wuxi) Bio-Pharmaceutical
  50. 7.9.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
  51. 7.9.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
  52. 7.9.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Portfolio
  54. 7.9.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
  55. 7.10 Emergent Biosolutions
  56. 7.10.1 Emergent Biosolutions Company Information
  57. 7.10.2 Emergent Biosolutions Business Overview
  58. 7.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Emergent Biosolutions Pneumonia Vaccine Product Portfolio
  60. 7.10.5 Emergent Biosolutions Recent Developments
  61. 7.11 CSL Limited
  62. 7.11.1 CSL Limited Company Information
  63. 7.11.2 CSL Limited Business Overview
  64. 7.11.3 CSL Limited Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 CSL Limited Pneumonia Vaccine Product Portfolio
  66. 7.11.5 CSL Limited Recent Developments
  67. 7.12 Astrazeneca Plc.
  68. 7.12.1 Astrazeneca Plc. Company Information
  69. 7.12.2 Astrazeneca Plc. Business Overview
  70. 7.12.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Astrazeneca Plc. Pneumonia Vaccine Product Portfolio
  72. 7.12.5 Astrazeneca Plc. Recent Developments
  73. 7.13 Astellas Pharma Inc.
  74. 7.13.1 Astellas Pharma Inc. Company Information
  75. 7.13.2 Astellas Pharma Inc. Business Overview
  76. 7.13.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Astellas Pharma Inc. Pneumonia Vaccine Product Portfolio
  78. 7.13.5 Astellas Pharma Inc. Recent Developments
8 North America
  1. 8.1 North America Pneumonia Vaccine Market Size by Type
  2. 8.1.1 North America Pneumonia Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Pneumonia Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Pneumonia Vaccine Price by Type (2021-2032)
  5. 8.2 North America Pneumonia Vaccine Market Size by Application
  6. 8.2.1 North America Pneumonia Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Pneumonia Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Pneumonia Vaccine Price by Application (2021-2032)
  9. 8.3 North America Pneumonia Vaccine Market Size by Country
  10. 8.3.1 North America Pneumonia Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pneumonia Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pneumonia Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pneumonia Vaccine Market Size by Type
  2. 9.1.1 Europe Pneumonia Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pneumonia Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Pneumonia Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Pneumonia Vaccine Market Size by Application
  6. 9.2.1 Europe Pneumonia Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pneumonia Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Pneumonia Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Pneumonia Vaccine Market Size by Country
  10. 9.3.1 Europe Pneumonia Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pneumonia Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pneumonia Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pneumonia Vaccine Market Size by Type
  2. 10.1.1 China Pneumonia Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Pneumonia Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Pneumonia Vaccine Price by Type (2021-2032)
  5. 10.2 China Pneumonia Vaccine Market Size by Application
  6. 10.2.1 China Pneumonia Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Pneumonia Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Pneumonia Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pneumonia Vaccine Market Size by Type
  2. 11.1.1 Asia Pneumonia Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pneumonia Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Pneumonia Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Pneumonia Vaccine Market Size by Application
  6. 11.2.1 Asia Pneumonia Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pneumonia Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Pneumonia Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Pneumonia Vaccine Market Size by Country
  10. 11.3.1 Asia Pneumonia Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pneumonia Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pneumonia Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pneumonia Vaccine Market Size by Type
  2. 12.1.1 SAMEA Pneumonia Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pneumonia Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pneumonia Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Pneumonia Vaccine Market Size by Application
  6. 12.2.1 SAMEA Pneumonia Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pneumonia Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pneumonia Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Pneumonia Vaccine Market Size by Country
  10. 12.3.1 SAMEA Pneumonia Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pneumonia Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pneumonia Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pneumonia Vaccine Value Chain Analysis
  2. 13.1.1 Pneumonia Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pneumonia Vaccine Production Mode & Process
  6. 13.2 Pneumonia Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pneumonia Vaccine Distributors
  9. 13.2.3 Pneumonia Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst